•
Sep 30, 2018

Cocrystal Pharma Q3 2018 Earnings Report

EPS
-$0.06
Previous year: -$0.08
-25.0%
Cash and Equivalents
$4.71M
Previous year: $1.35M
+250.4%
Free Cash Flow
-$2.16M
Previous year: -$2.19M
-1.3%
Total Assets
$124M
Previous year: $122M
+1.6%

Cocrystal Pharma

Cocrystal Pharma